Mehta Ishani, Juneja Keshav, Nimmakayala Tharun, Bansal Lajpat, Pulekar Shivani, Duggineni Dileep, Ghori Hana Khan, Modi Nishi, Younas Salma
Psychiatry and Behavioral Sciences, Maharaja Agrasen Institute of Medical Research and Education, Hisar, IND.
Psychiatry, BJ Medical College, Ahmedabad, IND.
Cureus. 2025 Mar 30;17(3):e81447. doi: 10.7759/cureus.81447. eCollection 2025 Mar.
The human gut flora of trillions of bacteria is vital for general health and greatly influences digestion, immune system function, and brain development. Through neuronal, hormonal, and immunological channels, the gut-brain axis (GBA), a bidirectional communication network, links the gut microbiota to the central nervous system (CNS). This relationship has been linked to affective diseases, including depression and anxiety, as well as mental health issues. This review explores the intricate relationship between gut bacteria and mood disorders, focusing on how gut microbiota-host interactions, immune system modulation, and neurotransmitter control support mental health. The function of important microbial metabolites, including short-chain fatty acids (SCFAs), in preserving blood-brain barrier integrity and modulating neuroinflammation is covered in this review. It also examines the bidirectional impact between gut health and mental health, including how dysbiosis could aggravate mood disorders and how depressed states might change the composition of gut bacteria. Furthermore, we discuss how psychotropic drugs affect gut flora and consider other elements such as nutrition and lifestyle that affect gut microbiome composition. Potential paths for treating mood disorders through gut microbiota modification are presented as emerging treatment techniques, including probiotics, nutritional therapies, and precision medicine. The development of new therapeutic approaches for mood disorders depends on the awareness of the GBA. Gut bacteria significantly affect mental health through immune modulation, neurotransmitter generation, and other intricate processes. Future studies should concentrate on large, varied populations to better understand these interactions and to create customized treatments that combine gut microbiota modulation with conventional mental health therapies.
由数万亿细菌组成的人类肠道菌群对整体健康至关重要,并对消化、免疫系统功能和大脑发育有很大影响。肠道-脑轴(GBA)作为一个双向通信网络,通过神经元、激素和免疫通道将肠道微生物群与中枢神经系统(CNS)联系起来。这种关系与包括抑郁症和焦虑症在内的情感疾病以及心理健康问题有关。本综述探讨了肠道细菌与情绪障碍之间的复杂关系,重点关注肠道微生物群与宿主的相互作用、免疫系统调节和神经递质控制如何支持心理健康。本综述涵盖了重要微生物代谢产物的功能,包括短链脂肪酸(SCFAs)在维持血脑屏障完整性和调节神经炎症方面的作用。它还研究了肠道健康与心理健康之间的双向影响,包括生态失调如何加重情绪障碍以及抑郁状态如何改变肠道细菌的组成。此外,我们讨论了精神药物如何影响肠道菌群,并考虑了其他影响肠道微生物群组成的因素,如营养和生活方式。通过改变肠道微生物群来治疗情绪障碍的潜在途径作为新兴治疗技术被提出,包括益生菌、营养疗法和精准医学。情绪障碍新治疗方法的开发取决于对肠道-脑轴的认识。肠道细菌通过免疫调节、神经递质生成和其他复杂过程显著影响心理健康。未来的研究应集中在大规模、多样化的人群上,以更好地理解这些相互作用,并创建将肠道微生物群调节与传统心理健康疗法相结合的定制治疗方法。